Generics Firms On Standby With Tecfidera Appeal Due ‘At Any Time’
Implication Of Potential Pro-Biogen Ruling Unclear
Biogen feels a decision on its appeal over Tecfidera is due any day now, but management was cautious over the potential to scrub the market of generics following market formation last year.
